With a robust career rooted in healthcare technology, Richard Sproll has emerged as a distinguished leader in digital health innovation. His experience spans over two decades of driving growth and operational excellence within startups and established enterprises alike. Recognized for his acumen in product development, he plays a pivotal role in shaping strategies that enhance patient care through technological advancements. Sproll's commitment to transforming health systems makes him an influential figure at the intersection of entrepreneurship and investment, drawing interest from investors looking to capitalize on disruptive trends in the industry.
With a robust career rooted in healthcare technology, Richard Sproll has emerged as a distinguished leader in digital health innovation. His experience spans over two decades of driving growth and operational excellence within startups and established enterprises alike. Recognized for his acumen in product development, he plays a pivotal role in shaping strategies that enhance patient care through technological advancements. Sproll's commitment to transforming health systems makes him an influential figure at the intersection of entrepreneurship and investment, drawing interest from investors looking to capitalize on disruptive trends in the industry.
In the rapidly evolving landscape of healthcare technology, Richard Sproll’s insights guide his investment approach toward impactful innovations. His strategic foresight enables the identification of high-potential ventures that not only enhance operational efficiencies but also improve patient outcomes. With a blend of entrepreneurial experience and an in-depth understanding of market dynamics, he prioritizes investments in startups poised for disruption. This focus on technological advancement underlines a commitment to shaping a healthier future through scalable solutions, making him a vital ally for entrepreneurs seeking to transform their visions into reality.
In the rapidly evolving landscape of healthcare technology, Richard Sproll’s insights guide his investment approach toward impactful innovations. His strategic foresight enables the identification of high-potential ventures that not only enhance operational efficiencies but also improve patient outcomes. With a blend of entrepreneurial experience and an in-depth understanding of market dynamics, he prioritizes investments in startups poised for disruption. This focus on technological advancement underlines a commitment to shaping a healthier future through scalable solutions, making him a vital ally for entrepreneurs seeking to transform their visions into reality.
| Trades 884 | Longs Won 371/884 41% | Profit Factor 1.78 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $752,956.72 |
| Average Win $467,572.06 | Best Trade (Sep 30) $9.52M | Sharpe Ratio -311.03 |
| Average Loss -$190,085.54 | Worst Trade (Jun 30) -$6.76M | Z-Score -7.88 (100%) |
| Commissions $0 | Avg. Trade Length 9m 5d | Expectancy $85,922.34 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 1,718 | 1,546 | 1,375 | 1,203 | 1,031 | 859 | 687 | 515 | 344 | 172 |